DIVIDEND ANNOUNCEMENT: Lilly (Eli) & Co (NYSE:LLY) on 06/27/2022 declared a dividend of $0.9800 per share

Lilly (Eli) & Co (NYSE:LLY) on 06/27/2022 declared a dividend of $ 0.9800 per share payable on September 09, 2022 to shareholders of record as of August 15, 2022.

Lilly (Eli) & Co (NYSE:LLY) has paid dividends since 1885, has a current dividend yield of 1.2038573027% and has increased its dividends for 7 successive years.

Lilly (Eli) & Co's market cap is $ 309,391,099,200 and has a PE ratio of 48.31. The stock price closed yesterday at $ 325.62 and has a 52 week low/high of $ 220.20 and $ 325.82.

Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s products include: diabetes products, oncology products, immunology products, neuroscience products, and other therapies. Co.'s diabetes products include: Baqsimi®, Basaglar®, Humalog®, Humulin®, Jardiance®, Lyumjev®, Trajenta®, and Trulicity®. Co.'s oncology products include: Alimta®, Cyramza®, Erbitux®, Retevmo®, Tyvyt®, and Verzenio®. Co.'s immunology products include: Olumiant® and Taltz®. Co.'s neuroscience products include: Cymbalta®, Emgality®, Reyvow®, and Zyprexa®. Co.'s other therapies include: Bamlanivimab, Cialis®, and Forteo®.

For more information on Lilly (Eli) & Co click here.